Table 1.
| Variable | HTLV− (N = 1,333) | HTLV1+ (N = 76) |
|---|---|---|
| Age in years: mean (standard deviation) | 44.05 (12.99) | 51.87 (14.29) |
| Sex: count (percent) | ||
| Male | 638 (47.86%) | 28 (36.84%) |
| Female | 695 (52.14%) | 48 (63.16%) |
| Infection duration in years: median (interquartile range) | 7 (8) | 6 (9) |
| Country of origin: count (percent) | ||
| Brazil | 83 (6.95%) | 2 (2.99%) |
| France | 346 (28.98%) | 17 (25.37%) |
| Guyana | 123 (10.3%) | 7 (10.45%) |
| Haiti | 397 (33.25%) | 17 (25.37%) |
| Caribbean other than Haiti | 23 (1.93%) | 3 (4.48%) |
| Surinam | 199 (28.36%) | 19 (28.36%) |
| Others | 23 (1.93%) | 2 (2.99%) |
| Contamination mode | ||
| Heterosexual sex | 1,199 (94.93%) | 71 (98.61%) |
| Homosexual sex | 47 (3.72%) | 1 (1.39%) |
| Mother to child | 10 (0.79%) | 0 |
| Intravenous (transfusion or intravenous drug use) | 7 (0.55%) | 0 |
| CDC clinical stage: count (percent) | ||
| A | 737 (55.29%) | 41 (53.92%) |
| B | 182 (13.65%) | 8 (10.53%) |
| C | 414 (31.06%) | 27 (35.53%) |
*
HTLV = human T lymphotropic virus; CDC = Centers for Disease Control and Prevention.